HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$11.21
Day range
$10.82 - $12.00
Year range
$10.00 - $29.60
Market cap
51.37M USD
Avg Volume
92.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 8.46M | -67.44% |
Operating expense | 17.59M | 309.28% |
Net income | -10.33M | -421.78% |
Net profit margin | -122.01 | -1,087.94% |
Earnings per share | -2.28 | -480.00% |
EBITDA | -10.66M | -454.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 29.02M | -39.52% |
Total assets | 52.72M | -35.50% |
Total liabilities | 70.50M | 28.41% |
Total equity | -17.78M | — |
Shares outstanding | 4.56M | — |
Price to book | -2.87 | — |
Return on assets | -44.64% | — |
Return on capital | 324.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.33M | -421.78% |
Cash from operations | -6.64M | 39.03% |
Cash from investing | -23.00K | 75.53% |
Cash from financing | -93.00K | -100.35% |
Net change in cash | -6.76M | -144.34% |
Free cash flow | -1.53M | 84.62% |
About
Founded
2012
Headquarters
Website
Employees
69